hide message

What do you think about our communications?

Our website received over 2 million visits last year. We delivered briefings, analysis and met with hundreds of local groups across the world.

We want to understand our audiences better and ensure that our communications, content and products are meeting your needs and driving impact. We would be very grateful if you could input into a quick survey on our communications activities.

Please take 2 minutes to complete a short survey

Thank you

Go to survey hide message

You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
en/doctors-without-borders-criticises-johnson-johnson-for-not-sharing-hiv-drug-patents-that-would-allow-access-for-poor-in-developing-countries#c58182

Johnson & Johnson takes heat from Doctors Without Borders for not sharing HIV drug patents [USA]

Author: Susan Todd, Star Ledger [USA], Published on: 25 April 2011

Doctors without Borders criticized Johnson & Johnson today for refusing to make patents on three HIV drugs available to a program that would reduce the cost of the medicines in developing countries…"Johnson & Johnson…has chosen to turn its back on these patients’’ [said Sophie Delaunay, a spokeswoman for Doctors Without Borders]. In an e-mail today, the New Brunswick-based healthcare giant said it preferred to provide access to its compounds through agreements with generic manufacturers. One of its latest agreements was announced in February…

Read the full post here

Related companies: Johnson & Johnson Tibotec (part of Johnson & Johnson)